LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma

NCT03090659 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory or Relapsed Multiple Myeloma

Interventions

BIOLOGICAL: LCAR-B38M CAR-T cell injection

Sponsor

Nanjing Legend Biotech Co.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]